Access Genomics Services
Our commitment to excellence in the scientific field of fertility mandates that we stay informed and connected with global leaders and innovators in genomics and genetic research technology. This allows us to offer you the latest, most effective, evidence-based screening services.


Preimplantation Genetic Testing for Aneuploidy is proven to be effective at identifying chromosomally normal (euploid) and chromosomally abnormal (aneuploid) embryos. It is an accurate, safe, and cost-effective genetics screening service that helps fertility clinics improve the implantation rate for their patients’ success rate for a healthy pregnancy.


Non-invasive prenatal testing (NIPT), also known as cell-free DNA (cfDNA) screening, is a safe, simple and reliable method of screening for common chromosome abnormalities as early as 10 weeks into pregnancy. A simple blood test is all that’s required, and results will be received within 5 days.

Genetic Counselling

Access Genomics’ board-certified counsellors, work in collaboration with your fertility physician, to explain genetic risks, and the genetic screening options available.


Products of Conception (POC) testing is a type of genomic screening that can help determine if a pregnancy loss was due to chromosome abnormalities.